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Introduction
The purpose of this editorial is to offer a synopsis about the COVID-19 pandemic and to 
present some recommendations as they relate to the practice of radiology, focused on Low- 
and Middle-Income Countries (LMIC). Health departments and professional bodies around 
the world are issuing guidelines for personal protection and patient handling in radiology. In 
High-Income Countries (HIC) these guidelines have been periodically updated as knowledge 
evolves about COVID-19 viral disease (1,2,3). The HIC guidelines assume the availability of 
portable radiography, ability to reserve one of many CT scanners only for COVID-19 patients, 
supply of a whole range of personal protective equipment (PPE), sanitizers and a variety 
of disinfecting chemicals. Nevertheless the exponential spread of COVID-19 is causing 
shortages of supplies in regions with supposedly “unlimited” resources. Much continues 
to be published on the rapidly evolving body of knowledge on this highly contagious 
respiratory infection, with a much higher mortality compared to the Influenza-A virus 
responsible for respiratory disease during “flu season” (4). Concurrently, speculative and false 
information is being exchanged on social media by “experts” from all walks of life offering 
“science” on the current pandemic. We urge our readers to use resources from established 
health organizations and universities, many of whom are referenced in this editorial.
Rationing requires that healthcare providers and institutions think about saving total life-
years rather than focusing on each individual patient. COVID-19 has strained healthcare 
systems worldwide and has resulted in actions being taken in HIC that would have been 
considered unthinkable three months ago. In addition to the life-or-death rationing of 
ventilators and other critical healthcare resources based on factors such as patient age, 
notably in Italy, the US Centers for Disease Control and Prevention made the unprecedented 
suggestion in March 2020 that in healthcare facilities with shortages of PPEs, bandanas 
or scarves could be substituted for medical facemasks as a last resort (5). We include this 
description not as an endorsement of suboptimal care and rationing, but as a recognition 
that LMIC, which have routinely faced the need to ration resources, will face the same painful 
choices as HIC have in this pandemic, and that difficult decisions and creative solutions will 
go hand-in-hand in dealing with this crisis.
About COVID-19
COVID-19 is a disease caused by a virus now named SARS-CoV-2. It is a new, highly contagious 
member of the family of coronaviruses. It is often referred to as Novel Coronavirus, because 
the virus is new to humans, likely having originated (like SARS-CoV and MERS-CoV) in bats 
or pangolins, hence the absence of preexisting human immunity. Three factors are primarily 
responsible for the rapid spread of COVID-19. First, people who are infected can transmit 
the virus for several days prior to becoming symptomatic. Second, the disease is often not 
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severe at its onset, so that people can continue to engage 
in work/social contact. Third, the virus seems more capable 
of persisting in the human population than SARS (SARS-CoV 
virus) so that the pandemic is unlikely to burn itself out. 
COVID-19 is principally spread by airborne droplets or via 
contaminated hands touching the face. The reproduction 
number or degree of infectivity of COVID-19, the R0 
(R-naught), is 3 (1.4-3.9) (6). This means that each infected 
person, whether symptomatic or not, is spreading the virus 
to three individuals. If that spread continues unabated 
through 10 cycles, one person would infect 59,000 people. 
As a comparison, the Influenza-A Pandemic of 1918 (“Spanish 
Flu”) had an R0 of 1.8 (1.4-2.8) so that, in 10 cycles, one person 
would infect only 357 individuals. That pandemic caused 50 
million deaths worldwide (6).
Currently, there is no known treatment or vaccine for 
COVID-19 virus. Supportive care appears to reduce mortality 
for those with moderate to severe infection. Prevention by 
containment and transmission reduction are the primary 
measures to reduce morbidity and mortality. The basis for 
this strategy is Universal Precautions. It is therefore prudent 
to assume that every individual is a carrier and any surface 
they touch is potentially infectious, unless disinfection has 
been performed. 
Imaging guidelines
Policy statements with guidelines for the use of imaging in 
patients with COVID-19 have been published by both the 
American College of Radiology (ACR) and the European 
Society of Radiology (ESR) (7,8). The Radiological Society 
of North America published on the reporting of chest CT 
findings related to COVID-19 (9) and, while a proposal for 
standards in the use of lung ultrasound has been published 
in the Journal of Ultrasound in Medicine (10), the role of 
ultrasound in the clinical diagnosis and management of 
patients with COVID-19 is rapidly evolving. 
Neither the ACR and ESR recommend chest X-ray or CT in 
the initial diagnosis of COVID-19. In the personal experience 
of the author in days prior to writing this editorial, many 
radiologists are confirming what was initially reported 
from Wuhan (10), that on the basis of rounded ground glass 
opacities in lower lungs, the diagnosis of COVID-19 viral 
pneumonia can be proposed even if the molecular test is 
negative. This is particularly important, as RT-PCR (reverse 
transcription polymerase chain reaction) testing using nasal 
swabs may have a false negative rate of up to 30% (11). 
Chest X-ray, ultrasound, and CT can be used in the clinical 
management of hospitalized patients, although guidelines 
caution that the use of CT should be selective. Given the 
rapidity of the pandemic, all the published reports on 
lung ultrasound are uncontrolled, but there is a subjective 
consensus that ultrasound’s portability, ease of use, and lack 
of radiation exposure offer advantages in monitoring disease 
progression and influencing management decisions. 
The ACR and ESR guidelines should not be construed as 
negating the role of chest X-ray in the management of 
patients with COVID-19. The guidelines are consistent, to 
a large degree, with the Basildon Protocol – Diagnostic 
Imaging Protocol version 2 [United Kingdom], which 
recommends chest X-ray in high-risk patients and those 
with severe disease and, if radiographic findings are atypical, 
recommends the performance of chest CT (12). 
Ultrasound, more widely available in LMIC than CT, is 
showing promise in the diagnosis and management of 
COVID-19 infection. Ultrasound shows septal thickening 
(B-lines) and lung consolidation (13). This modality requires 
familiarity with these findings to make a diagnosis. 
Readers are urged to read the excellent article by Soldati 
G. et al, which includes a proposed grading scheme and 
standardized acquisition protocols (10). 
For readers interested in a summary of the imaging findings 
in COVID-19 and current recommendations for the use of 
imaging, this journal plans to publish a follow-up article over 
the next few days.
Best practices for infection control
In departments of radiology, as in daily life in general, “social 
distancing” and disinfection must be practiced. General 
guidelines on facility preparation and management have 
been published by Partners In Health (PIH), in part based 
on their experience in the Ebola epidemic (14), and RSNA 
has published guidelines specific to radiology departments 
(3). To assist radiologists in breaking the cycle of spread and 
protecting both personnel and patients, what follows are our 
recommendations based on these guidelines:
  Postpone all non-essential imaging studies once a 
COVID-19 outbreak occurs regionally. This both avoids 
the potential for cross-infection to patients and protects 
the technologist workforce, prolonging their efficacy 
in an outbreak. It also reduces the strain on supplies, 
personnel, and facilities.
  Ensure that all radiology personnel are familiar with 
standard infection prevention and control measures for 
COVID-19 and the locally available PPE.
  Perform daily attestation checks on personnel regarding 
any symptomatology including dry cough, fever, new 
sore throat, anosmia, etc. 
  All patients entering radiology should wear masks, 
and staff should wear masks and gloves. With known 
COVID-19 infection, staff should use the available 
Personal Protective Equipment (PPE) including mask, 
caps, gloves, eye protection, protective gown/overall for 
clothes, and shoe covers. If masks are not available for 
both patients and staff, staff should be prioritized both 
for efficiency and because of their repeated exposure. 
  Train and implement standard operating procedures 
(SOPs) for equipment decontamination and 
handwashing/sanitization.
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  Ensure that adequate resources are available, proximate 
to radiology, for handwashing (or, if running water is not 
proximate, hand sanitization).
  Determine if adjacent areas, such as control rooms, etc. 
can be further separated to minimize the airborne spread 
of infection using room isolation tarps with zipper access.
  Close off any non-essential spaces adjacent to sites where 
patients with COVID-19 are imaged.
  Assess personnel and equipment workflow to maximize 
the available PPE and minimize the interaction between 
personnel and infected patients, and restrict access 
to radiology for any non-essential personnel or family 
members.
  Consult operating manuals or companies as to whether 
alternative cleaning solutions, such as dilute bleach, can 
be used on equipment. Such solutions are likely to be 
more widely available during a crisis than specialized 
disinfectant wipes. Note that dilute bleach solutions lose 
their efficacy and should be disposed of after 24 hours.
  Use mobile imaging (radiography and ultrasound), where 
applicable.
  If more than one piece of imaging equipment is available, 
consider dedicating one unit to COVID-19 patients, 
which will reduce the workload and supplies required for 
decontamination.
  Adequate decontamination of equipment is time-
consuming. Imaging workflow for patients with known 
COVID-19 infection should be distinguished from imaging 
patients with possible infection. If specific equipment 
cannot be dedicated to COVID-19 patients, equipment 
should be utilized first with asymptomatic patients, 
then symptomatic patients, and lastly with confirmed 
COVID-19 cases. Patients with confirmed COVID-19 
infection can be imaged as a cohort before performing 
full decontamination.
  If facilities are planning to designate specific areas (fever 
tents, etc.) to the triage of suspected patients, determine 
the most effective strategy for associated imaging 
workup, including mobile imaging.
In the current COVID-19 pandemic, a shortage of PPE exists 
in HIC. In the United States, emergency measures are being 
taken to recycle used PPE after sterilization and temporary 
instructions have been published by the Food and Drug 
Administration (FDA) to prepare decontamination products 
(15). LMIC must begin preparations with near certainty that 
the pandemic will affect their regions. Self-reliance and 
improvisation will be necessary to fill supply-demand gap 
for resources required to reduce transmission in healthcare 
facilities, particularly to healthcare providers. Extraordinary 
times require extraordinary measures. Measures unthinkable 
under normal circumstance may be employed during a 
lethal pandemic. Public participation in sewing masks, caps, 
and gowns using recyclable local materials have become 
common to limit mortality both within and outside hospitals. 
Previously unimaginable numbers of such products must 
be produced as nations prepare to deal with the COVID-19 
pandemic. Under exceptional circumstances, any materials 
that can be cleansed with disinfectant solutions, such as 
raincoats, ponchos, plastic sheets and even clean trash bags 
may be used for personal protection by staff and patients. A 
variety of protective gloves are used in healthcare and other 
industries. Any type of non-porous gloves may be used for 
protection. 
The US-based Food and Drug Administration (FDA) has 
issued a temporary policy on the production of hand 
sanitizer and antiseptic alcohol-based products. These can 
be used for wiping down equipment and countertops and 
for hand hygiene (15).
The ingredients are as follows:
  Active ingredients: Ethanol 80% volume/volume (v/v) 
in aqueous solution OR Isopropyl Alcohol 75% v/v in 
aqueous solution. 
  Inactive ingredients: Glycerol 1.45% v/v, Hydrogen 
peroxide 0.125% v/v, distilled or boiled water.
Proper handwashing with soap and water several times a 
day is a worldwide practice. In healthcare, handwashing 
remains the hallmark of infection control. Handwashing with 
proper technique is pivotal in containing the pandemic. As a 
reminder, the guidelines are as follows (16): 
1. Wet your hands with clean, running water (warm or cold), 
turn off the tap, and apply soap.
2. Lather your hands by rubbing them together with the 
soap. Lather the backs of your hands, between your 
fingers, and under your nails.
3. Scrub your hands for at least 20 seconds by watch. Need 
a timer? Hum the “Happy Birthday” song from beginning 
to end twice.
4. Rinse your hands well under clean, running water.
5. Turn off water with foot pedal or using a towel. 
6. Dry your hands using a clean towel or air-dry them.
Testing and treatment
Current COVID-19 tests, RT-PCR, are based on amplifying 
viral RNA from nasopharyngeal swabs. On average, results 
from this test can take days in the US. With this turnaround 
time (TAT), the ability to perform millions of tests – necessary 
in a pandemic – does not exist. Scientists are working on 
tests with a shorter TAT, and the FDA recently approved a 
portable, point-of-care test that can deliver a positive result 
in as little as five minutes (17). 
RT-PCR tests can help diagnose current cases of COVID-19, 
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but they cannot determine whether someone has had 
the infection and since recovered. Serological testing can 
detect antibodies present in anyone who has recovered 
from COVID-19. The FDA has just approved a fingerprick test 
for antibodies to the SARS-CoV 2 virus (18) and one US-
based company is already shipping their fingerprick test to 
countries outside the US while FDA approval is pending (19).
Scientists around the world are working on drugs and 
a vaccine for COVID-19 infection. Currently, there is no 
vaccine against COVID-19, and the widespread production 
of a vaccine is unlikely until at least 2021. The utility of 
antimalarial drugs, antiviral drugs, and BCG inoculation have 
been proposed to fight the pandemic but there are, as yet, 
no conclusive studies. Experts, such as Jerome Grossman, 
caution about the widespread use of untested therapies (20).
Conclusion
While we hope that this information helps in preparation 
and action for the COVID-19 pandemic, new information 
about COVID-19 is being added on a daily basis. Readers 
are therefore urged to frequently check reliable sources for 
the latest knowledge about the pandemic: departments of 
health in their own countries, the World Health Organization 
(WHO), US Centers for Disease Control and Prevention 
(CDC), American College of Radiology, Royal College of 
Radiologists, and European Society of Radiology (1,2,21-23).
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